New Four-Pronged weapon tested against tough blood cancers
NCT ID NCT05104775
Summary
This is an early-stage study to check the safety and find the right dose of a new drug called GNC-035. The drug is a special antibody designed to attack cancer cells in four different ways. It is being tested in adults with advanced blood cancers that have come back or have not responded to other treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOLOGIC MALIGNANCIES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Affiliated Hospital of Guizhou Medical University
Guiyang, Guizhou, China
-
Guangzhou First People's Hospital
Guangzhou, Guangdong, China
-
Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Shanghai, Shanghai Municipality, 200025, China
-
Shengjing Hospital of China Medical University
Shenyang, Liaoning, China
-
The Fourth Hospital of Hebei Medical University
Shijiazhuang, Hebei, China
-
The Second People's Hospital of Yibin
Yibin, Sichuang, China
-
Union Hospital Tongji Medical College Huazhong University of Science and Technology
Wuhan, Hubei, China
Conditions
Explore the condition pages connected to this study.